Products

What will AGI do for Atenolol?

This classification denotes a beta-adrenergic blocking agent with the molecular formula C14H22N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 50VV3VW0TI, chemically known as ici 66,082 but generally known as atenolol, which bears US NIH Compound Identifier 2249. Atenolol comes in many forms, including base, acetate, acid, diacetate, hydrochloride, methylboronate, and n-butylboronate. European Medicines Agency schedules Atenolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05590MIG. The term ATENOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). World Health Organization schedules atenolol in its Anatomical Therapeutic Chemical (ATC) Classification. ATENOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule atenolol under HS 29242995 and SITC 51479. As of Q4 2014, ATENOLOL remains the US FDA Preferred Term for this commodity. Atenolol bears US NLM identifiers UMLS ID C0004147 and NCI Concept Code C28836. SMILES: O(CC(O)CNC(C)C)C1CCC(CC1)CC(=O)N.